Come up with a name for your new list and we'll add to it:
20/20 GeneSystems raised a round of funding on September 29, 2008. Investors include
National Cancer Institute.
20/20 GeneSystems has developed, validated, and undergone clinical testing of a blood test for the early detection of lung cancer. The test measures a panel of tumor biomarkers and utilizes a propriet…